Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in Target Drug Molecules for Alzheimer's Disease
Jiayang Xie, Ruirui Liang, Yan‐Jiang Wang, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 20, Iss. 1, pp. 4-36
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Metal–Organic Frameworks as Sensors for Human Amyloid Diseases
José P. Leite, Flávio Figueira, Ricardo F. Mendes, et al.
ACS Sensors (2023) Vol. 8, Iss. 3, pp. 1033-1053
Open Access | Times Cited: 41
iATC-NFMLP: Identifying Classes of Anatomical Therapeutic Chemicals Based on Drug Networks, Fingerprints, and Multilayer Perceptron
Shunrong Tang, Lei Chen
Current Bioinformatics (2022) Vol. 17, Iss. 9, pp. 814-824
Closed Access | Times Cited: 41
Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges
Tong Wu, Lin Ding, Ya‐Qian Cheng, et al.
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1745-1745
Open Access | Times Cited: 39
Oligodendrocyte progenitor cells in Alzheimer’s disease: from physiology to pathology
Peibin Zou, Chongyun Wu, Timon Cheng‐Yi Liu, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction
Simone Giovannuzzi, Daniel Chavarria, Gustavo Provensi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 4170-4193
Closed Access | Times Cited: 9
β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy
Aurélien Beato, Anthonin Gori, Benjamin Boucherle, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 3, pp. 1392-1422
Open Access | Times Cited: 55
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease
Santosh R. D’Mello
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5911-5911
Open Access | Times Cited: 51
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease
Wenjie Liu, Limeng Wu, Wenwu Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114689-114689
Closed Access | Times Cited: 35
Mesenchymal stromal cells for the treatment of Alzheimer’s disease: Strategies and limitations
Shobha Regmi, Daniel Dan Liu, Michelle Shen, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 25
An integrated study on the comprehensive mechanism of Schisandra chinensis polysaccharides mitigating Alzheimer's disease in rats using a UPLC-Q-TOF-MS based serum and urine metabolomics strategy
Jun Fu, Jixun Li, Yuzhen Sun, et al.
Food & Function (2022) Vol. 14, Iss. 2, pp. 734-745
Closed Access | Times Cited: 24
Lingguizhugan decoction ameliorates cognitive impairment in AD-like mice by influencing the microbiome–gut–brain axis mediated by SCFAs
Lisha Du, Jun Chen, Jianyi Yan, et al.
Phytomedicine (2024) Vol. 133, pp. 155942-155942
Closed Access | Times Cited: 5
The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer’s Disease
Xiaodong Liu, Zhe Lv, Qin Huang, et al.
Neurochemical Research (2025) Vol. 50, Iss. 1
Closed Access
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Research progress and perspectives of dual-target inhibitors
Xiaojing Pang, Wenyan Xu, Jing Liang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117453-117453
Closed Access
Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease
Changjun Zhang, Yangjing Lv, Renren Bai, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105070-105070
Closed Access | Times Cited: 27
Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease
E. F. Shevtsova, Andrey V. Maltsev, Darya V. Vinogradova, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 803-827
Closed Access | Times Cited: 31
Photobiomodulation for Hypertension and Alzheimer’s Disease
Audrey Valverde, John Mitrofanis
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 3, pp. 1045-1055
Open Access | Times Cited: 18
Evodiamine: A Privileged Structure with Broad-ranging Biological Activities
Wenwu Liu, Qingchun Zhao, Deping Li, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 21, pp. 2680-2701
Closed Access | Times Cited: 16
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment
Wenjie Liu, Liting Tian, Limeng Wu, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106168-106168
Closed Access | Times Cited: 15
Palladium-Catalyzed Synthesis, Acetylcholinesterase Inhibition, and Neuroprotective Activities of N-Aryl Galantamine Analogues
Yang Zhang, Jin‐Bu Xu, Yao Xiao, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 4, pp. 939-946
Closed Access | Times Cited: 7
Rational design, synthesis and computational studies of multi-targeted anti-Alzheimer’s agents integrating coumarin scaffold
Menna M. A. Abd El‐Mageed, Manal Abdel Fattah Ezzat, Shaimaa A. Moussa, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108024-108024
Closed Access | Times Cited: 2
Acteoside and ursolic acid synergistically protects H 2 O 2 -induced neurotrosis by regulation of AKT/mTOR signalling: from network pharmacology to experimental validation
Yan-Jie Qu, Min-Rui Ding, Chao Gu, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 1751-1761
Open Access | Times Cited: 12
A Comprehensive Analysis Identified Hub Genes and Associated Drugs in Alzheimer’s Disease
Qi Jing, Hui Zhang, Xiaoru Sun, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 13
Drug–Target Interaction Prediction Based on an Interactive Inference Network
Yuqi Chen, Xiaomin Liang, Wei Du, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7753-7753
Open Access | Times Cited: 1
Design, synthesis, in silico, and in vitro evaluation of pyrrol-2-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors
Amit Sharma, Santosh Rudrawar, Ankita Sharma, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 26703-26722
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top